Register Login

Alto Neuroscience Inc. (ANRO)

Director York Gwill 🟢 acquired 5.2K shares (1 derivative) of Alto Neuroscience, Inc. (ANRO) at $16.59 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 11:11 p.m.

    🔍 York Gwill (Director)

    Company: Alto Neuroscience, Inc. (ANRO)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 5,243

    Detailed Transactions and Holdings:

    • Acquired 5,243 shares of Stock Option (right to buy) at $16.59 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 5,243.00 | transaction_form_type: 4 | Footnotes: F2, F1

    Footnotes:

    • F1: 1,311 shares underlying the option shall vest on March 31, 2026, 1,311 shares underlying the option shall vest on June 30, 2026, 1,310 shares underlying the option shall vest on September 30, 2026 and 1,311 shares underlying the option shall vest on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.
    • F2: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $62,000.

Search

News categories